Vulvovaginal candidosis is an infection caused by fungi of the genus Candida, primarily affecting the external genitalia, vagina, intercrural region, and perianal area. Approximately 85–95% of cases are attributed to Candida albicans. Symptoms typically include pruritus, erythema, burning sensations, dyspareunia, dysuria, and vaginal discharge. Diagnosis relies upon patient medical history, clinical manifestations, and microscopic identification of the organism. Treatment often involves local and systemic antifungal agents. Non-albicans species, such as Candida glabrata, Candida tropicalis, and Candida parapsilosis, present therapeutic challenges. Intermittent antifungal therapy may be advocated for patients experiencing recurrent candidosis. Vaginal antifungal treatments are generally considered safe during pregnancy. Preventive strategies encompass hygienic practices and management of underlying conditions.